Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy
Crossref DOI link: https://doi.org/10.1007/s10528-016-9782-5
Published Online: 2016-11-30
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kanca, Deniz
Gormus, Uzay
Tokat, Bengu
Eronat, Allison P.
Bugra, Zehra
Ozturk, Oğuz
Yilmaz-Aydogan, Hulya
Funding for this research was provided by:
Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi (T-709/280699)
License valid from 2016-11-30